These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 15492610)

  • 21. Chronic hepatitis C genotype 6 responds better to pegylated interferon and ribavirin combination therapy than genotype 1.
    Tsang OT; Zee JS; Chan JM; Li RS; Kan YM; Li FT; Lo FH; Chow DA; Cheung KW; Chan KH; Yeung YW; Ng FH; Li MK; Kwan WK; Lai TS
    J Gastroenterol Hepatol; 2010 Apr; 25(4):766-71. PubMed ID: 20492332
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Celiac disease is not associated with chronic hepatitis C.
    Thevenot T; Boruchowicz A; Henrion J; Nalet B; Moindrot H;
    Dig Dis Sci; 2007 May; 52(5):1310-2. PubMed ID: 17372827
    [No Abstract]   [Full Text] [Related]  

  • 23. Daily or three times a week interferon alfa-2b in combination with ribavirin or interferon alone for the treatment of patients with chronic hepatitis C.
    de Lédinghen V; Trimoulet P; Winnock M; Foucher J; Bourlière M; Desmorat H; Canva V; Capron D; Lévy S; Mion F; Mannant PR; Chêne G; Fleury H; Couzigou P; Bernard PH;
    J Hepatol; 2002 May; 36(5):672-80. PubMed ID: 11983451
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Psychiatric symptoms induced by antiviral therapy in chronic hepatitis C: comparison between interferon-alpha-2a and interferon-alpha-2b.
    Neri S; Pulvirenti D; Bertino G
    Clin Drug Investig; 2006; 26(11):655-62. PubMed ID: 17163300
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluation of the adverse effect of premature discontinuation of pegylated interferon α-2b and ribavirin treatment for chronic hepatitis C virus infection: results from Kyushu University Liver Disease Study.
    Ogawa E; Furusyo N; Kajiwara E; Takahashi K; Nomura H; Tanabe Y; Satoh T; Maruyama T; Nakamuta M; Kotoh K; Azuma K; Dohmen K; Shimoda S; Hayashi J;
    J Gastroenterol Hepatol; 2012 Jul; 27(7):1233-40. PubMed ID: 22098185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and tolerance of interferon-alpha(2b) in the treatment of chronic hepatitis C virus infection in haemodialysis patients. Pre- and post-renal transplantation assessment.
    Campistol JM; Esforzado N; Martínez J; Roselló L; Veciana L; Modol J; Casellas J; Pons M; de Las Cuevas X; Piera J; Oliva JA; Costa J; Barrera JM; Bruguera M
    Nephrol Dial Transplant; 1999 Nov; 14(11):2704-9. PubMed ID: 10534516
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pegylated-interferon alpha 2a treatment for chronic hepatitis C in patients on chronic haemodialysis.
    Sporea I; Popescu A; Sirli R; Golea O; Totolici C; Danila M; Vernic C
    World J Gastroenterol; 2006 Jul; 12(26):4191-4. PubMed ID: 16830372
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C.
    Friedrich-Rust M; Theobald J; Zeuzem S; Bojunga J
    J Viral Hepat; 2009 Mar; 16(3):168-77. PubMed ID: 19175874
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Organ-specific autoimmunity and genetic predisposition in interferon-treated HCV-related chronic hepatitis patients.
    Floreani A; Chiaramonte M; Greggio NA; Fabris P; De Lazzari F; Naccarato R; Betterle C
    Ital J Gastroenterol Hepatol; 1998 Feb; 30(1):71-6. PubMed ID: 9615270
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Combined treatment of relapse of chronic hepatitis C with high-dose alpha2b interferon plus ribavirin for 6 or 12 months.
    Di Marco V; Almasio P; Vaccaro A; Ferraro D; Parisi P; Cataldo MG; Di Stefano R; Craxì A
    J Hepatol; 2000 Sep; 33(3):456-62. PubMed ID: 11020002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Autoimmune hemolytic anemia presenting during treatment of chronic hepatitis C with interferon alpha].
    Rizzi R; Lucarella FP; Ruggieri GB; L'Abbate M
    Ann Ital Med Int; 2003; 18(2):107-10. PubMed ID: 12886829
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Late onset autoimmune thrombocytopenia associated with pegylated interferon-alpha-2b plus ribavirin treatment for chronic hepatitis C.
    Elefsiniotis IS; Pantazis KD; Fotos NV; Moulakakis A; Mavrogiannis C
    J Gastroenterol Hepatol; 2006 Mar; 21(3):622-3. PubMed ID: 16638114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut mucosal immunity to tissue transglutaminase in untreated celiac disease and other gastrointestinal disorders.
    Dahele A; Aldhous MC; Kingstone K; Humphreys K; Bode J; McIntyre M; Ghosh S
    Dig Dis Sci; 2002 Oct; 47(10):2325-35. PubMed ID: 12395906
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Interferon-induced Parkinsonism in a patient with chronic hepatitis C.
    Almeida CM; Galvão Mde L; Ferreira PL; Braga WS
    Arq Neuropsiquiatr; 2009 Sep; 67(3A):715-6. PubMed ID: 19722060
    [No Abstract]   [Full Text] [Related]  

  • 35. High levels of immunoglobulin A anti-tissue transglutaminase antibodies at diagnosis are a predictive factor for celiac hepatitis.
    Albuquerque A; Rodrigues S; Macedo G
    Scand J Gastroenterol; 2016 Nov; 51(11):1316-20. PubMed ID: 27387923
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pericarditis due to interferon-alpha therapy during treatment for chronic hepatitis C.
    Gressens B; Gohy P
    Acta Gastroenterol Belg; 2004; 67(3):301-2. PubMed ID: 15587340
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An adult case with onset of celiac disease during chronic hepatitis C antiviral treatment.
    Ioniţă-Radu F; Bucurică S; Costache R; Nuţă P; Stanciu S
    Rom J Intern Med; 2010; 48(1):105-8. PubMed ID: 21180248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Parkinsonism in patients with chronic hepatitis C treated with interferon-alpha2b: a report of two cases.
    Kajihara M; Montagnese S; Khanna P; Amodio P; Schapira AH; Dusheiko GM; Morgan MY
    Eur J Gastroenterol Hepatol; 2010 May; 22(5):628-31. PubMed ID: 20075741
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Pegylated interferon alpha-2b plus ribavirin as therapy for chronic hepatitis C in HIV-infected patients.
    Callens S; Bottieau E; Michielsen P; Colebunders R
    AIDS; 2004 Jan; 18(1):131. PubMed ID: 15090841
    [No Abstract]   [Full Text] [Related]  

  • 40. Distinct clinical courses in type 1 diabetes mellitus induced by peg-interferon-alpha treatment for chronic hepatitis C.
    Yamazaki M; Sato A; Takeda T; Komatsu M
    Intern Med; 2010; 49(5):403-7. PubMed ID: 20190473
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.